Clinical Trial Update: Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating adding cisplatin to neoadjuvant therapy for locally advanced breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Breast Cancer
• Invasive Ductal Carcinoma of the Breast
• Mucinous Carcinoma of the Breast
• Tubular Carcinoma of the Breast

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: RenJi Hospital | Conditions: Tubular Breast Cancer, Mucinous Breast Cancer | Phase 2 | Status: COMPLETED